Isracann Receives Project Characterization Report and Engages EU GMP Consultancy
Extensive report details project infrastructure advantages, efficiencies and opportunities from inception to production VANCOUVER, BC, — (January 9, 2020) – Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company”) an Israel-based company focused on becoming a premier low cost, high quality cannabis producer for both domestic and European export sales, is pleased to...